PubMed

High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients. A randomized trial.

Singh N, Yu VL, Mieles L, Wagener MM, Miner RC, Gayowski T.

Ann Intern Med. 1994 Mar 1;120(5):375-81.PMID: 8304654 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte antibody therapy.

Turgeon N, Fishman JA, Basgoz N, Tolkoff-Rubin NE, Doran M, Cosimi AB, Rubin RH.

Transplantation. 1998 Dec 27;66(12):1780-6.PMID: 9884276 [PubMed - indexed for MEDLINE]Related articles

A prospective randomized trial comparing sequential ganciclovir-high dose acyclovir to high dose acyclovir for prevention of cytomegalovirus disease in adult liver transplant recipients.

Martin M, Mañez R, Linden P, Estores D, Torre-Cisneros J, Kusne S, Ondick L, Ptachcinski R, Irish W, Kisor D, et al.

Transplantation. 1994 Oct 15;58(7):779-85.PMID: 7940710 [PubMed - indexed for MEDLINE]Related articles

Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients.

Winston DJ, Wirin D, Shaked A, Busuttil RW.

Lancet. 1995 Jul 8;346(8967):69-74.PMID: 7603215 [PubMed - indexed for MEDLINE]Related articles

Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients.

Winston DJ, Busuttil RW.

Transplantation. 2003 Jan 27;75(2):229-33.PMID: 12548129 [PubMed - indexed for MEDLINE]Related articles

Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.

Rubin RH, Kemmerly SA, Conti D, Doran M, Murray BM, Neylan JF, Pappas C, Pitts D, Avery R, Pavlakis M, Del Busto R, DeNofrio D, Blumberg EA, Schoenfeld DA, Donohue T, Fisher SA, Fishman JA.

Transpl Infect Dis. 2000 Sep;2(3):112-7.PMID: 11429021 [PubMed - indexed for MEDLINE]Related articles

A randomized prospective controlled trial of oral acyclovir versus oral ganciclovir for cytomegalovirus prophylaxis in high-risk kidney transplant recipients.

Flechner SM, Avery RK, Fisher R, Mastroianni BA, Papajcik DA, O'Malley KJ, Goormastic M, Goldfarb DA, Modlin CS, Novick AC.

Transplantation. 1998 Dec 27;66(12):1682-8.PMID: 9884259 [PubMed - indexed for MEDLINE]Related articles

Cytomegalovirus antigenemia directed pre-emptive prophylaxis with oral versus I.V. ganciclovir for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, controlled trial.

Singh N, Paterson DL, Gayowski T, Wagener MM, Marino IR.

Transplantation. 2000 Sep 15;70(5):717-22.PMID: 11003347 [PubMed - indexed for MEDLINE]Related articles

Prophylaxis of cytomegalovirus infection in liver transplantation: a randomized trial comparing a combination of ganciclovir and acyclovir to acyclovir. NIDDK Liver Transplantation Database.

Badley AD, Seaberg EC, Porayko MK, Wiesner RH, Keating MR, Wilhelm MP, Walker RC, Patel R, Marshall WF, DeBernardi M, Zetterman R, Steers JL, Paya CV.

Transplantation. 1997 Jul 15;64(1):66-73.PMID: 9233703 [PubMed - indexed for MEDLINE]Related articles

Efficacy of valganciclovir administered as preemptive therapy for cytomegalovirus disease in liver transplant recipients: impact on viral load and late-onset cytomegalovirus disease.

Singh N, Wannstedt C, Keyes L, Gayowski T, Wagener MM, Cacciarelli TV.

Transplantation. 2005 Jan 15;79(1):85-90.PMID: 15714174 [PubMed - indexed for MEDLINE]Related articles

Prospective comparison of valacyclovir and oral ganciclovir for prevention of cytomegalovirus disease in high-risk renal transplant recipients.

Reischig T, Opatrný Jr K, Treska V, Mares J, Jindra P, Svecová M.

Kidney Blood Press Res. 2005;28(4):218-25. Epub 2005 Jul 21.PMID: 16043964 [PubMed - indexed for MEDLINE]Related articles

Prevention of recurrent cytomegalovirus disease in renal and liver transplant recipients: effect of oral ganciclovir.

Turgeon N, Fishman JA, Doran M, Basgoz N, Tolkoff-Rubin NE, Cosimi AB, Rubin RH.

Transpl Infect Dis. 2000 Mar;2(1):2-10.PMID: 11429003 [PubMed - indexed for MEDLINE]Related articles

Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients.

Noble S, Faulds D.

Drugs. 1998 Jul;56(1):115-46. Review.PMID: 9664203 [PubMed - indexed for MEDLINE]Related articles

Comparative study of prophylactic oral ganciclovir and valacyclovir in high-risk kidney transplant recipients.

Yango A, Morrissey P, Zanabli A, Beaulieu J, Shemin D, Dworkin L, Monaco A, Gohh R.

Nephrol Dial Transplant. 2003 Apr;18(4):809-13.PMID: 12637653 [PubMed - indexed for MEDLINE]Related articlesFree article

Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial.

Hibberd PL, Tolkoff-Rubin NE, Conti D, Stuart F, Thistlethwaite JR, Neylan JF, Snydman DR, Freeman R, Lorber MI, Rubin RH.

Ann Intern Med. 1995 Jul 1;123(1):18-26.PMID: 7762909 [PubMed - indexed for MEDLINE]Related articlesFree article

Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.

Becker BN, Becker YT, Leverson GE, Simmons WD, Sollinger HW, Pirsch JD.

Am J Kidney Dis. 2002 May;39(5):1088-95.PMID: 11979354 [PubMed - indexed for MEDLINE]Related articles

Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients?

Jain A, Orloff M, Kashyap R, Lansing K, Betts R, Mohanka R, Menegus M, Ryan C, Bozorgzadeh A.

Transplant Proc. 2005 Sep;37(7):3182-6.PMID: 16213344 [PubMed - indexed for MEDLINE]Related articles

Successful prophylaxis of cytomegalovirus disease after primary CMV exposure in liver transplant recipients.

Stratta RJ, Shaefer MS, Cushing KA, Markin RS, Wood RP, Langnas AN, Reed EC, Woods GL, Donovan JP, Pillen TJ, et al.

Transplantation. 1991 Jan;51(1):90-7.PMID: 1846254 [PubMed - indexed for MEDLINE]Related articles

Randomized controlled trial of sequential intravenous and oral ganciclovir versus prolonged intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in high-risk cytomegalovirus-seronegative liver transplant recipients with cytomegalovirus-seropositive donors.

Winston DJ, Busuttil RW.

Transplantation. 2004 Jan 27;77(2):305-8.PMID: 14742998 [PubMed - indexed for MEDLINE]Related articles

Preemptive use of oral ganciclovir to prevent cytomegalovirus infection in liver transplant patients: a randomized, placebo-controlled trial.

Paya CV, Wilson JA, Espy MJ, Sia IG, DeBernardi MJ, Smith TF, Patel R, Jenkins G, Harmsen WS, Vanness DJ, Wiesner RH.

J Infect Dis. 2002 Apr 1;185(7):854-60. Epub 2002 Mar 19.PMID: 11920308 [PubMed - indexed for MEDLINE]Related articles